🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A 3-day Course for CFS/ME

RecruitingNAAges 18 Years - 65 YearsAllNorwegian University of Science and Technology
NCT05236465 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Chronic fatigue syndrome/Myalgic encephalomyelitis (CFS/ME) can be a serious and disabling condition with a heavy symptom burden and low function. Work disability is common, and social life dramatically affected. CFS/ME is a challenging health problem as well as a societal problem. In recent years, a doubling of the number of patients with a CFS/ME diagnoses has been reported in Norway. The patient group represents a challenge for the health care system, the municipality, and the Norwegian Labour and Welfare Organization (NAV). According to new figures, the NAV pays 100 million Norwegian Kroner (NOK) each month in permanently incapacitated expenses for people with CFS/ME. Municipalities have expenses in form of care, rehabilitation and other measures. There is a lack of effective treatment for CFS/ME. Evidence-based knowledge is highly needed. If the 3-day course shows promising effec

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * CFS/ME diagnosis based on the Canada Consensus Criteria. * At least 50% out of school/work. * Readiness to change (corresponding to the preparation phase in transtheoretical model) * Has given informed consent. Exclusion Criteria: * Assessed by a General Practitioner (GP): * Underlying physical illness or mental disorder that may explain the symptoms. * Suicide risk/previous suicide attempts. * Pregnancy. * Bedridden and in need of continuous care. * Insufficient Norwegian speaking or writing skills to participate in the 3-day course and fill out questionnaires.
💊

What it tests

  • A 3-day course
  • Waiting list
📍

Where

1 site
Department of Psychology, NTNU
Trondheim, Norway
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy